These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 11132163)
41. 32P liquid sources--comparison of the effectiveness of postangioplasty versus poststenting intravascular brachytherapy in hypercholesterolemic rabbits. Adjunctly implanted titanium stent does not attenuate the effect of endovascular irradiation. Walichiewicz P; Petelenz B; Wilczek K; Jacheć W; Jochem J; Tomasik A; Lange D; Wodniecki J Cardiovasc Radiat Med; 2003; 4(2):64-8. PubMed ID: 14581085 [TBL] [Abstract][Full Text] [Related]
42. [Catheter-assisted techniques for decreasing the rate of restenosis after coronary angioplasty: an overview of radiotherapy]. Hehrlein C; Brachmann J; Bode C; Kübler W Z Kardiol; 1998; 87 Suppl 2():166-70. PubMed ID: 9827476 [TBL] [Abstract][Full Text] [Related]
43. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents. Albiero R; Nishida T; Adamian M; Amato A; Vaghetti M; Corvaja N; Di Mario C; Colombo A Circulation; 2000 May; 101(21):2454-7. PubMed ID: 10831516 [TBL] [Abstract][Full Text] [Related]
50. Supplemental oxygen does not synergize with intracoronary radiation for the prevention of restenosis in porcine coronary arteries. Vodovotz Y; Bhargava B; Chan RC; Collins S; Zalesky P; Thompson A; Waksman R Cardiovasc Radiat Med; 1999; 1(2):138-43. PubMed ID: 11229546 [TBL] [Abstract][Full Text] [Related]
51. Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosis. Carter AJ; Jenkins S; Sweet W; Bailey L; Jones R; Fischell TA; Virmani R Cardiovasc Radiat Med; 1999; 1(4):327-35. PubMed ID: 10828562 [TBL] [Abstract][Full Text] [Related]
52. Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re liquid-filled balloon. Schühlen H; Eigler N; Whiting JS; Haubner R; Hausleiter J; Dirschinger J; Kastrati A; Schwaiger M; Schömig A Am J Cardiol; 2001 Feb; 87(4):463-6, A7. PubMed ID: 11179537 [TBL] [Abstract][Full Text] [Related]
53. Novel approaches for the prevention of restenosis. Gruberg L; Waksman R; Satler LF; Pichard AD; Kent KM Expert Opin Investig Drugs; 2000 Nov; 9(11):2555-78. PubMed ID: 11060820 [TBL] [Abstract][Full Text] [Related]
54. Endovascular brachytherapy in the prevention of vascular restenosis. Dvorák J; Fridrich J; Raupach J; Petera J; Krajina A; Lojík M; Masková J; Vodnanský P; Zoul Z; Odrázka K; Kalousová D; Chovanec V Cardiovasc Radiat Med; 2001; 2(3):130-2. PubMed ID: 11786317 [TBL] [Abstract][Full Text] [Related]
56. A novel 32P deployable balloon system inhibits formation of neointima in porcine coronary arteries after balloon-overstretching injury. Kim HS; Kollum M; Chan RC; Trauthen B; Cottin Y; Bhargava B; Fournadjiev J; Yazdi HA; Waksman R Coron Artery Dis; 2001 Jun; 12(4):317-22. PubMed ID: 11428541 [TBL] [Abstract][Full Text] [Related]
57. Methods to improve dose uniformity for radioactive stents in endovascular brachytherapy. Amols HI Cardiovasc Radiat Med; 1999; 1(3):270-7. PubMed ID: 11272372 [TBL] [Abstract][Full Text] [Related]
58. Dose distribution for a 32P-impregnated coronary stent: comparison of theoretical calculations and measurements with radiochromic film. Duggan DM; Coffey CW; Levit S Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):713-20. PubMed ID: 9486624 [TBL] [Abstract][Full Text] [Related]
59. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Amols HI; Zaider M; Weinberger J; Ennis R; Schiff PB; Reinstein LE Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):913-21. PubMed ID: 8960521 [TBL] [Abstract][Full Text] [Related]